GlaxoSmithKline said today that the Food and Drug Administration has approved its vaccine Boostrix for tetanus, diphtheria and whooping cough for adults.
GlaxoSmithKline said today that the Food and Drug Administration has approved its vaccine Boostrix for tetanus, diphtheria and whooping cough for adults.